My pesonal research on Dec. 11th lead me to Purdue as well as mentioned in the post below. However, one of the point which catched my attention is the fact that Purdue is ONE OF THE MOST IMPORTANT private company appointed by the TRUMP COMMISSION ON OPIOID CRISIS. This is a MAJOR door opening for Tetra in the "NEW POST OPIOID ERA" if everything goes well for their # DIN. I imagine Purdue CAN'T sell Tetra product considering potential interest conflict, Rhodes can! Times will tell. For now this is a strategic move that FEW OTHER TETRA COMPETITORS HAVEN'T SEEN IN THE REARVIEW MIRROR !!!
These are some points mentioned on their factsheet.
-Investing in research to develop non-opioid pain medications.
-Delivering the US Surgeon General’s TurnTheTideRx materials, which review considerations when prescribing opioids for chronic pain, to healthcare professionals.
-Sharing the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain with thousands of prescribers and pharmacists.
-Supporting the National Sheriffs’ Association (NSA) with a grant to provide front-line officers with the rescue drug naloxone.
-Working with the National Institutes of Health (NIH) as part of President Trump’s Opioid Commission on a public-private partnership focused on the development of non-addictive pain medications, innovative addition deterrent formulas and treatments for overdose.
Factsheet link https://www.purduepharma.com/about/company-values/strong-track-record/ http://www.stockhouse.com/companies/bullboard/v.tbp/tetra-bio-pharma-inc?postid=29095650
..This situation MIGHT BE ONE OF THE REASON TETRA SP has been so seriously...bullied after each good news. Hopefully this will stop by the next summer..